Cargando…
Follow-up after Direct-acting Antiviral Treatment for Chronic Hepatitis C Virus Infection: Most Patients Are Followed Appropriately
OBJECTIVE: Chronic hepatitis C virus (HCV) infection carries a residual risk of hepatocarcinogenesis even after viral elimination, so appropriate follow-up is necessary. The present study investigated the current hospital visits and hepatocarcinogenesis status of patients who received daclatasvir pl...
Autores principales: | Tojima, Hiroki, Kakizaki, Satoru, Takakusagi, Satoshi, Hoshino, Takashi, Naganuma, Atsushi, Nagashima, Tamon, Namikawa, Masashi, Ueno, Takashi, Shimada, Yasushi, Hatanaka, Takeshi, Takizawa, Daichi, Arai, Hirotaka, Sato, Ken, Takagi, Hitoshi, Uraoka, Toshio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8545640/ https://www.ncbi.nlm.nih.gov/pubmed/34602520 http://dx.doi.org/10.2169/internalmedicine.6591-20 |
Ejemplares similares
-
Liver Function Changes in Patients with Hepatocellular Carcinoma Treated with Lenvatinib: Predictive Factors of Progression to Child-Pugh Class B, the Formation of Ascites and the Candidates for the Post-Progression Treatment
por: Hatanaka, Takeshi, et al.
Publicado: (2020) -
Changes of esophageal varices in hepatitis C patients after achievement of a sustained viral response by direct‐acting antivirals
por: Takakusagi, Satoshi, et al.
Publicado: (2021) -
Effect of 48‐week pemafibrate on non‐alcoholic fatty liver disease with hypertriglyceridemia, as evaluated by the FibroScan‐aspartate aminotransferase score
por: Hatanaka, Takeshi, et al.
Publicado: (2021) -
Impact of the Prognostic Nutritional Index on the Survival of Japanese Patients with Hepatocellular Carcinoma Treated with Sorafenib: A Multicenter Retrospective Study
por: Hatanaka, Takeshi, et al.
Publicado: (2019) -
Prognosis of late elderly patients with chronic hepatitis C after achieving a sustained viral response by direct‐acting antivirals
por: Takakusagi, Satoshi, et al.
Publicado: (2020)